Status:
NOT_YET_RECRUITING
Studying Patterns in Patient Engagement Among Tardive Dyskinesia Patients
Lead Sponsor:
Power Life Sciences Inc.
Conditions:
Tardive Dyskinesia
Eligibility:
All Genders
18+ years
Brief Summary
The statistical analysis of the collected data aims to reveal the many factors that influence patient involvement in clinical trials. Findings will be disseminated through conferences and scholarly pa...
Eligibility Criteria
Inclusion
- Diagnosis of tardive dyskinesia
- Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
- No prior treatment for tardive dyskinesia
Exclusion
- Enrolled in another research study
- Inability to provide written informed consent
- Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
Key Trial Info
Start Date :
February 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06218719
Start Date
February 1 2025
End Date
February 1 2027
Last Update
January 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Power Life Sciences
San Francisco, California, United States, 94107